Amrize Ltd (AMRZ) earnings date, results and what the price requires
NYSE · SEC CIK 0002035989 · SEC filings checked Oct 19, 2026
Previous results (SEC filings)
| Quarter ended | Reported | Revenue | Net income | Diluted EPS | Source |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 6, 2026 | $3.49B | $478.0M | $0.86 | Filing |
| Mar 31, 2026 | Apr 29, 2026 | $2.18B | $-105.0M | $-0.19 | Filing |
| Dec 31, 2025 | Feb 17, 2026 | $2.83B | $317.0M | $0.58 | Filing |
| Sep 30, 2025 | Oct 28, 2025 | $3.67B | $545.0M | $0.98 | Filing |
| Jun 30, 2025 | Aug 6, 2025 | $3.22B | $417.0M | $0.75 | Filing |
| Mar 31, 2025 | — | $2.09B | $-94.0M | $-0.17 | — |
| Sep 30, 2024 | — | $3.45B | $553.0M | $1.00 | — |
| Jun 30, 2024 | — | $3.24B | $474.0M | $0.86 | — |
What would Amrize Ltd have to report for its valuation to change?
At $37.32, with a 9.0% required return and a 18× earnings multiple in 5 years, earnings per share must grow about 7.4% a year, to $3.19. On that path the next quarter needs diluted EPS near $1.05, against $0.98 in the quarter ended Sep 30, 2025.
Compare buying at the last close now with waiting for results: if the report moves the growth the price requires, the entry price you would accept changes with it.
| Result | Original | Yours |
|---|---|---|
| Required EPS growth / year | 7.4% | 7.4% |
| EPS needed in final year | $3.19 | $3.19 |
Changed: nothing yet. Model: EPS × (1+g)^years × final P/E, discounted at the required return, equals today's price. Inputs: SEC diluted EPS and the dated close above.
Prepare for earnings across my investments — $399/month
Keep working models for the companies you follow, compare your expectations with reported results, and review what changes your investment decision. AMRZ goes in with your buy-or-wait comparison and assumptions preserved.
Figures come from SEC EDGAR XBRL filings. Dates marked "estimated" are calculated from the company's past results filings and are not confirmed. Not investment advice.